Clinical Trial Update: Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combination of celecoxib with fluorouracil and leucovorin for patients with resected stage III colon cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Celecoxib (Celecoxib)
• Leucovorin (folinic acid)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED